Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Tissue Technologies is a medical technology company specializing in the development of innovative wound care and regenerative medicine solutions. The company is best known for EZ Derm, a porcine-derived biosynthetic xenograft used for the treatment of partial-thickness burns and chronic wounds. EZ Derm provides a temporary skin substitute that promotes healing and protects the wound bed while offering the convenience of room-temperature storage. In 2016, the company was acquired by Mölnlycke Health Care, a global leader in medical products and solutions. This acquisition integrated ATT's specialized tissue technologies into Mölnlycke's extensive wound care portfolio, expanding the reach of its burn care treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Tissue Technologies.